-
1
-
-
0025169590
-
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
-
Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
-
(1990)
Science
, vol.249
, pp. 1436-1438
-
-
Bergman, H.1
Wichmann, T.2
DeLong, M.R.3
-
2
-
-
0028796071
-
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
-
Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
-
(1995)
Lancet
, vol.345
, pp. 91-95
-
-
Limousin, P.1
Pollak, P.2
Benazzouz, A.3
-
3
-
-
0032491507
-
Experimental therapeutics of neurodegenerative disorders: Unmet needs
-
Shoulson I. Experimental therapeutics of neurodegenerative disorders: unmet needs. Science 1998;282:1072-1074.
-
(1998)
Science
, vol.282
, pp. 1072-1074
-
-
Shoulson, I.1
-
4
-
-
58349122472
-
Why have we failed to achieve neuroprotection in Parkinson's disease?
-
Olanow CW, Kieburtz K, Schapira AH. Why have we failed to achieve neuroprotection in Parkinson's disease? Ann Neurol 2008;64(suppl 2):S101-S110.
-
(2008)
Ann Neurol
, vol.64
, Issue.SUPPL. 2
-
-
Olanow, C.W.1
Kieburtz, K.2
Schapira, A.H.3
-
6
-
-
67651160657
-
Neuroprotection trials in Parkinson's disease: Systematic review
-
Hart RG, Pearce LA, Ravina BM, et al. Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord 2009;24:647-654.
-
(2009)
Mov Disord
, vol.24
, pp. 647-654
-
-
Hart, R.G.1
Pearce, L.A.2
Ravina, B.M.3
-
7
-
-
0034671450
-
Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease
-
Eberhardt O, Coelln RV, Kugler S, et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2000;20:9126-9134.
-
(2000)
J Neurosci
, vol.20
, pp. 9126-9134
-
-
Eberhardt, O.1
Coelln, R.V.2
Kugler, S.3
-
8
-
-
10744223673
-
Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease
-
Hayley S, Crocker SJ, Smith PD, et al. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2004;24:2045-2053.
-
(2004)
J Neurosci
, vol.24
, pp. 2045-2053
-
-
Hayley, S.1
Crocker, S.J.2
Smith, P.D.3
-
9
-
-
38549134304
-
Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo
-
Chen X, Rzhetskaya M, Kareva T, et al. Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo. J Neurosci 2008;28:672-680.
-
(2008)
J Neurosci
, vol.28
, pp. 672-680
-
-
Chen, X.1
Rzhetskaya, M.2
Kareva, T.3
-
10
-
-
56749158302
-
JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration
-
Ries V, Silva RM, Oo TF, et al. JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. J Neurochem 2008;107:1578-1588.
-
(2008)
J Neurochem
, vol.107
, pp. 1578-1588
-
-
Ries, V.1
Silva, R.M.2
Oo, T.F.3
-
11
-
-
0034652278
-
Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases
-
Finn JT, Weil M, Archer F, et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000; 20:1333-1341.
-
(2000)
J Neurosci
, vol.20
, pp. 1333-1341
-
-
Finn, J.T.1
Weil, M.2
Archer, F.3
-
12
-
-
0037012844
-
Axonal self-destruction and neurodegeneration
-
Raff MC, Whitmore AV, Finn JT. Axonal self-destruction and neurodegeneration. Science 2002;296:868-871.
-
(2002)
Science
, vol.296
, pp. 868-871
-
-
Raff, M.C.1
Whitmore, A.V.2
Finn, J.T.3
-
13
-
-
27644591304
-
Axon degeneration mechanisms: Commonality amid diversity
-
Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005;6:889-898.
-
(2005)
Nat Rev Neurosci
, vol.6
, pp. 889-898
-
-
Coleman, M.1
-
14
-
-
0037333666
-
Staging of brain pathology related to sporadic Parkinson's disease
-
Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24:197-211.
-
(2003)
Neurobiol Aging
, vol.24
, pp. 197-211
-
-
Braak, H.1
Del Tredici, K.2
Rub, U.3
-
15
-
-
57749095477
-
A critical evaluation of the Braak staging scheme for Parkinson's disease
-
Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008;64:485-491.
-
(2008)
Ann Neurol
, vol.64
, pp. 485-491
-
-
Burke, R.E.1
Dauer, W.T.2
Vonsattel, J.P.3
-
16
-
-
68749116710
-
A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders
-
Jellinger KA. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 2009;1792:730-740.
-
(2009)
Biochim Biophys Acta
, vol.1792
, pp. 730-740
-
-
Jellinger, K.A.1
-
17
-
-
61949220753
-
The Parkinson chimera
-
Lees AJ. The Parkinson chimera. Neurology 2009;72:S2-S11.
-
(2009)
Neurology
, vol.72
-
-
Lees, A.J.1
-
18
-
-
0000595601
-
Biochemistry of neurotransmitters in Parkinson's disease
-
Marsden CD, Fahn S, eds. London, UK: Butterworths
-
Agid Y, Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders 2. London, UK: Butterworths, 1987:166-230.
-
(1987)
Movement Disorders 2
, pp. 166-230
-
-
Agid, Y.1
Agid, F.2
Ruberg, M.3
-
19
-
-
0025232430
-
Parkinson's disease
-
Marsden CD. Parkinson's disease. Lancet 1990;335:948-952.
-
(1990)
Lancet
, vol.335
, pp. 948-952
-
-
Marsden, C.D.1
-
20
-
-
4844226577
-
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
-
DOI 10.1002/ana.20226
-
Ross GW, Petrovitch H, Abbott RD, et al. Parkinsonian signs and substantia nigra neuron density in descendents elders without PD. Ann Neurol 2004;56:532-539. (Pubitemid 39319343)
-
(2004)
Annals of Neurology
, vol.56
, Issue.4
, pp. 532-539
-
-
Ross, G.W.1
Petrovitch, H.2
Abbott, R.D.3
Nelson, J.4
Markesbery, W.5
Davis, D.6
Hardman, J.7
Launer, L.8
Masaki, K.9
Tanner, C.M.10
White, L.R.11
-
21
-
-
0032497504
-
Parkinson's disease First of two parts
-
Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053.
-
(1998)
N Engl J Med
, vol.339
, pp. 1044-1053
-
-
Lang, A.E.1
Lozano, A.M.2
-
22
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
23
-
-
0025954066
-
Ageing and Parkinson's disease: Substantia nigra regional selectivity
-
Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
-
(1991)
Brain
, vol.114
, pp. 2283-2301
-
-
Fearnley, J.M.1
Lees, A.J.2
-
24
-
-
0342981758
-
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts
-
DOI 10.1016/S0022-510X(97)00100-7, PII S0022510X97001007
-
Ma SY, Roytta M, Rinne JO, et al. Correlation between neuro-morphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts. J Neurol Sci 1997;151:83-87. (Pubitemid 27398014)
-
(1997)
Journal of the Neurological Sciences
, vol.151
, Issue.1
, pp. 83-87
-
-
Ma, S.Y.1
Roytta, M.2
Rinne, J.O.3
Collan, Y.4
Rinne, U.K.5
-
25
-
-
33645749795
-
Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra
-
Greffard S, Verny M, Bonnet AM, et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006;63:584-588.
-
(2006)
Arch Neurol
, vol.63
, pp. 584-588
-
-
Greffard, S.1
Verny, M.2
Bonnet, A.M.3
-
26
-
-
0015745743
-
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
-
Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
-
(1973)
J Neurol Sci
, vol.20
, pp. 415-455
-
-
Bernheimer, H.1
Birkmayer, W.2
Hornykiewicz, O.3
-
27
-
-
0017082987
-
Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis
-
Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976;38:277-301.
-
(1976)
J Neural Transm
, vol.38
, pp. 277-301
-
-
Riederer, P.1
Wuketich, S.2
-
28
-
-
0024448235
-
Striatal dopamine deficiency in Parkinson's disease: Role of aging
-
Scherman D, Desnos C, Darchen F, et al. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 1989;26:551-557. (Pubitemid 19247232)
-
(1989)
Annals of Neurology
, vol.26
, Issue.4
, pp. 551-557
-
-
Scherman, D.1
Desnos, C.2
Darchen, F.3
Pollak, P.4
Javoy-Agid, F.5
Agid, Y.6
-
29
-
-
0023874410
-
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
-
Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880. (Pubitemid 18090271)
-
(1988)
New England Journal of Medicine
, vol.318
, Issue.14
, pp. 876-880
-
-
Kish, S.J.1
Shannak, K.2
Hornykiewicz, O.3
-
30
-
-
41149129792
-
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
-
Beach TG, Adler CH, Sue LI, et al. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 2008;115:445-451.
-
(2008)
Acta Neuropathol
, vol.115
, pp. 445-451
-
-
Beach, T.G.1
Adler, C.H.2
Sue, L.I.3
-
32
-
-
18844471416
-
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
-
Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000;47:493-503.
-
(2000)
Ann Neurol
, vol.47
, pp. 493-503
-
-
Lee, C.S.1
Samii, A.2
Sossi, V.3
-
33
-
-
0025964041
-
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
-
Pakkenberg B, Moller A, Gundersen HJ, et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 1991;54:30-33.
-
(1991)
J Neurol Neurosurg Psychiatry
, vol.54
, pp. 30-33
-
-
Pakkenberg, B.1
Moller, A.2
Gundersen, H.J.3
-
34
-
-
79251475537
-
The status of dopaminergic putaminal innervation in Parkinson's disease as a function of disease duration: Relevance to trophic factor therapy
-
Presentation 326.9
-
Dodiya HB, Chu Y, Beach TG, et al. The status of dopaminergic putaminal innervation in Parkinson's disease as a function of disease duration: relevance to trophic factor therapy. Abstr Soc Neurosci 2009, Presentation 326.9.
-
(2009)
Abstr Soc Neurosci
-
-
Dodiya, H.B.1
Chu, Y.2
Beach, T.G.3
-
35
-
-
22244442489
-
The biochemistry of Parkinson's disease
-
Cookson MR. The biochemistry of Parkinson's disease. Annu Rev Biochem 2005;74:29-52.
-
(2005)
Annu Rev Biochem
, vol.74
, pp. 29-52
-
-
Cookson, M.R.1
-
37
-
-
0033538002
-
Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry
-
DOI 10.1016/S0304-3940(99)00208-6, PII S0304394099002086
-
Braak H, Sandmann-Keil D, Gai W, et al. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 1999;265:67-69. (Pubitemid 29210200)
-
(1999)
Neuroscience Letters
, vol.265
, Issue.1
, pp. 67-69
-
-
Braak, H.1
Sandmann-Keil, D.2
Gai, W.3
Braak, E.4
-
38
-
-
0033539664
-
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein
-
Galvin JE, Uryu K, Lee VM, et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 1999;96: 13450-13455.
-
Proc Natl Acad Sci U S A 1999
, vol.96
, pp. 13450-13455
-
-
Galvin, J.E.1
Uryu, K.2
Lee, V.M.3
-
39
-
-
0036322266
-
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
-
Duda JE, Giasson BI, Mabon ME, et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002;52:205-210.
-
(2002)
Ann Neurol
, vol.52
, pp. 205-210
-
-
Duda, J.E.1
Giasson, B.I.2
Mabon, M.E.3
-
40
-
-
33846997878
-
Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with lewy bodies
-
DOI 10.1523/JNEUROSCI.4564-06.2007
-
Kramer ML, Schulz-Schaeffer WJ. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007;27:1405-1410. (Pubitemid 46255421)
-
(2007)
Journal of Neuroscience
, vol.27
, Issue.6
, pp. 1405-1410
-
-
Kramer, M.L.1
Schulz-Schaeffer, W.J.2
-
41
-
-
39749123263
-
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
-
DOI 10.1093/brain/awm302
-
Orimo S, Uchihara T, Nakamura A, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008;131:642-650. (Pubitemid 351294710)
-
(2008)
Brain
, vol.131
, Issue.3
, pp. 642-650
-
-
Orimo, S.1
Uchihara, T.2
Nakamura, A.3
Mori, F.4
Kakita, A.5
Wakabayashi, K.6
Takahashi, H.7
-
42
-
-
77953395313
-
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: Three questions
-
Greggio E, Cookson MR. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009;1:e00002.
-
(2009)
ASN Neuro
, vol.1
-
-
Greggio, E.1
Cookson, M.R.2
-
43
-
-
67649813448
-
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease
-
Li Y, Liu W, Oo TF, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009;12:826-828.
-
(2009)
Nat Neurosci
, vol.12
, pp. 826-828
-
-
Li, Y.1
Liu, W.2
Oo, T.F.3
-
44
-
-
33751256567
-
The familial Parkinsonism gene LRRK2 regulates neurite process morphology
-
MacLeod D, Dowman J, Hammond R, et al. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52:587-593.
-
(2006)
Neuron
, vol.52
, pp. 587-593
-
-
MacLeod, D.1
Dowman, J.2
Hammond, R.3
-
45
-
-
39549117093
-
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
-
Plowey ED, Cherra SJ III, Liu YJ, et al. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 2008;105:1048-1056.
-
(2008)
J Neurochem
, vol.105
, pp. 1048-1056
-
-
Plowey, E.D.1
Cherra III, S.J.2
Liu, Y.J.3
-
46
-
-
70449377127
-
Phosphorylation of ezrin/ radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis
-
Parisiadou L, Xie C, Cho HJ, et al. Phosphorylation of ezrin/ radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 2009;29:13971-13980.
-
(2009)
J Neurosci
, vol.29
, pp. 13971-13980
-
-
Parisiadou, L.1
Xie, C.2
Cho, H.J.3
-
47
-
-
34447118788
-
LRRK2 phosphorylates moesin at threonine-558: Characterization of how Parkinson's disease mutants affect kinase activity
-
Jaleel M, Nichols RJ, Deak M, et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007;405:307-317.
-
(2007)
Biochem J
, vol.405
, pp. 307-317
-
-
Jaleel, M.1
Nichols, R.J.2
Deak, M.3
-
48
-
-
0032547839
-
Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons
-
Paglini G, Kunda P, Quiroga S, et al. Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol 1998;143:443-455.
-
(1998)
J Cell Biol
, vol.143
, pp. 443-455
-
-
Paglini, G.1
Kunda, P.2
Quiroga, S.3
-
49
-
-
0031682676
-
Biochemical aspects of Parkinson's disease
-
Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998;51:S2-S9.
-
(1998)
Neurology
, vol.51
-
-
Hornykiewicz, O.1
-
50
-
-
0036774951
-
Axon pathology in neurological disease: A neglected therapeutic target
-
Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002;25:532-537.
-
(2002)
Trends Neurosci
, vol.25
, pp. 532-537
-
-
Coleman, M.P.1
Perry, V.H.2
-
51
-
-
0024373441
-
Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve
-
Lunn ER, Perry VH, Brown MC, et al. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1989;1:27-33.
-
(1989)
Eur J Neurosci
, vol.1
, pp. 27-33
-
-
Lunn, E.R.1
Perry, V.H.2
Brown, M.C.3
-
52
-
-
0034633627
-
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse
-
Conforti L, Tarlton A, Mack TG, et al. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 2000;97:11377-11382.
-
Proc Natl Acad Sci U S A 2000
, vol.97
, pp. 11377-11382
-
-
Conforti, L.1
Tarlton, A.2
Mack, T.G.3
-
53
-
-
0035195636
-
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
-
Mack TG, Reiner M, Beirowski B, et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001;4:1199-1206.
-
(2001)
Nat Neurosci
, vol.4
, pp. 1199-1206
-
-
Mack, T.G.1
Reiner, M.2
Beirowski, B.3
-
54
-
-
0027956623
-
Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis)
-
Deckwerth TL, Johnson EM Jr. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev Biol 1994;165:63-72.
-
(1994)
Dev Biol
, vol.165
, pp. 63-72
-
-
Deckwerth, T.L.1
Johnson Jr., E.M.2
-
55
-
-
0034747230
-
s protein protects against axonal degeneration: A model of gene therapy for peripheral neuropathy
-
DOI 10.1002/ana.10039
-
Wang MS, Fang G, Culver DG, et al. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann Neurol 2001;50:773-779. (Pubitemid 33116137)
-
(2001)
Annals of Neurology
, vol.50
, Issue.6
, pp. 773-779
-
-
Wang, M.S.1
Fang, G.2
Culver, D.G.3
Davis, A.A.4
Rich, M.M.5
Glass, J.D.6
-
56
-
-
13544273848
-
S, inhibits axonal spheroid pathology in gracile axonal dystrophy mice
-
DOI 10.1093/brain/awh368
-
Mi W, Beirowski B, Gillingwater TH, et al. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 2005;128:405-416. (Pubitemid 40222609)
-
(2005)
Brain
, vol.128
, Issue.2
, pp. 405-416
-
-
Mi, W.1
Beirowski, B.2
Gillingwater, T.H.3
Adalbert, R.4
Wagner, D.5
Grumme, D.6
Osaka, H.7
Conforti, L.8
Arnhold, S.9
Addicks, K.10
Wada, K.11
Ribchester, R.R.12
Coleman, M.P.13
-
57
-
-
23244436227
-
Axon retraction and degeneration in development and disease
-
DOI 10.1146/annurev.neuro.28.061604.135632
-
Luo L, O'Leary DD. Axon retraction and degeneration in development and disease. Annu Rev Neurosci 2005;28:127-156. (Pubitemid 41098902)
-
(2005)
Annual Review of Neuroscience
, vol.28
, pp. 127-156
-
-
Luo, L.1
O'Leary, D.D.M.2
-
58
-
-
1542380508
-
s-mediated protection of dopaminergic fibers in an animal model of Parkinson disease
-
DOI 10.1016/S0960-9822(04)00050-8, PII S0960982204000508
-
Sajadi A, Schneider BL, Aebischer P. Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol 2004;14:326-330. (Pubitemid 38300211)
-
(2004)
Current Biology
, vol.14
, Issue.4
, pp. 326-330
-
-
Sajadi, A.1
Schneider, B.L.2
Aebischer, P.3
-
59
-
-
33748432246
-
Wld(S) mice are protected against the Parkinsonian mimetic MPTP
-
Hasbani DM, O'Malley KL. Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 2006;202:93-99.
-
(2006)
Exp Neurol
, vol.202
, pp. 93-99
-
-
Hasbani, D.M.1
O'Malley, K.L.2
-
60
-
-
4043165678
-
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
-
DOI 10.1126/science.1098014
-
Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004;305:1010-1013. (Pubitemid 39071777)
-
(2004)
Science
, vol.305
, Issue.5686
, pp. 1010-1013
-
-
Araki, T.1
Sasaki, Y.2
Milbrandt, J.3
-
61
-
-
33744926927
-
The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons
-
MacDonald JM, Beach MG, Porpiglia E, et al. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 2006;50:869-881.
-
(2006)
Neuron
, vol.50
, pp. 869-881
-
-
MacDonald, J.M.1
Beach, M.G.2
Porpiglia, E.3
-
62
-
-
61449113031
-
Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
-
Conforti L, Wilbrey A, Morreale G, et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 2009;184:491-500.
-
(2009)
J Cell Biol
, vol.184
, pp. 491-500
-
-
Conforti, L.1
Wilbrey, A.2
Morreale, G.3
-
63
-
-
65649126738
-
Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide
-
Sasaki Y, Vohra BP, Lund FE, et al. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 2009;29:5525-5535.
-
(2009)
J Neurosci
, vol.29
, pp. 5525-5535
-
-
Sasaki, Y.1
Vohra, B.P.2
Lund, F.E.3
-
64
-
-
33748174151
-
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
-
DOI 10.1523/JNEUROSCI.2320-06.2006
-
Sasaki Y, Araki T, Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 2006;26:8484-8491. (Pubitemid 44316176)
-
(2006)
Journal of Neuroscience
, vol.26
, Issue.33
, pp. 8484-8491
-
-
Sasaki, Y.1
Araki, T.2
Milbrandt, J.3
-
65
-
-
61449233205
-
Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration
-
Avery MA, Sheehan AE, Kerr KS, et al. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol 2009;184:501-513.
-
(2009)
J Cell Biol
, vol.184
, pp. 501-513
-
-
Avery, M.A.1
Sheehan, A.E.2
Kerr, K.S.3
-
66
-
-
66049102890
-
Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration
-
Yahata N, Yuasa S, Araki T. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 2009;29:6276-6284.
-
(2009)
J Neurosci
, vol.29
, pp. 6276-6284
-
-
Yahata, N.1
Yuasa, S.2
Araki, T.3
-
67
-
-
0032440766
-
In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
-
Srinivasan A, Roth KA, Sayers RO, et al. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 1998;5:1004-1016.
-
(1998)
Cell Death Differ
, vol.5
, pp. 1004-1016
-
-
Srinivasan, A.1
Roth, K.A.2
Sayers, R.O.3
-
68
-
-
0034655408
-
Cytochrome c release and caspase activation in traumatic axonal injury
-
Buki A, Okonkwo DO, Wang KK, et al. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000;20:2825-2834. (Pubitemid 30220307)
-
(2000)
Journal of Neuroscience
, vol.20
, Issue.8
, pp. 2825-2834
-
-
Buki, A.1
Okonkwo, D.O.2
Wang, K.K.W.3
Povlishock, J.T.4
-
69
-
-
0035884951
-
Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons
-
Cowan CM, Thai J, Krajewski S, et al. Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons. J Neurosci 2001;21:7099-7109. (Pubitemid 32846957)
-
(2001)
Journal of Neuroscience
, vol.21
, Issue.18
, pp. 7099-7109
-
-
Cowan, C.M.1
Thai, J.2
Krajewski, S.3
Reed, J.C.4
Nicholson, D.W.5
Kaufmann, S.H.6
Roskams, A.J.7
-
70
-
-
0037037438
-
Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons
-
El-Khodor BF, Burke RE. Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J Comp Neurol 2002;452:65-79.
-
(2002)
J Comp Neurol
, vol.452
, pp. 65-79
-
-
El-Khodor, B.F.1
Burke, R.E.2
-
71
-
-
60549089207
-
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
-
Nikolaev A, McLaughlin T, O'Leary DD, et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009;457:981-989.
-
(2009)
Nature
, vol.457
, pp. 981-989
-
-
Nikolaev, A.1
McLaughlin, T.2
O'Leary, D.D.3
-
72
-
-
28244466782
-
CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism
-
Silva RM, Ries V, Oo TF, et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem 2005;95:974-986.
-
(2005)
J Neurochem
, vol.95
, pp. 974-986
-
-
Silva, R.M.1
Ries, V.2
Oo, T.F.3
-
73
-
-
0028865136
-
Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
-
Sagot Y, Dubois-Dauphin M, Tan SA, et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 1995;15:7727-7733.
-
(1995)
J Neurosci
, vol.15
, pp. 7727-7733
-
-
Sagot, Y.1
Dubois-Dauphin, M.2
Tan, S.A.3
-
74
-
-
22844445441
-
Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease
-
Silva RM, Kuan CY, Rakic P, et al. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease. Mov Disord 2005;20:653-664.
-
(2005)
Mov Disord
, vol.20
, pp. 653-664
-
-
Silva, R.M.1
Kuan, C.Y.2
Rakic, P.3
-
75
-
-
38449107680
-
Programmed cell death and new discoveries in the genetics of parkinsonism
-
Burke RE. Programmed cell death and new discoveries in the genetics of parkinsonism. J Neurochem 2008;104:875-890.
-
(2008)
J Neurochem
, vol.104
, pp. 875-890
-
-
Burke, R.E.1
-
76
-
-
35148882113
-
Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
-
The Parkinson Study Group PRECEPT Investigators
-
The Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 2007;69:1480-1490.
-
(2007)
Neurology
, vol.69
, pp. 1480-1490
-
-
-
77
-
-
33750207744
-
Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases
-
Waldmeier P, Bozyczko-Coyne D, Williams M, Vaught JL. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases. Biochem Pharmacol 2006;72:1197-1206.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 1197-1206
-
-
Waldmeier, P.1
Bozyczko-Coyne, D.2
Williams, M.3
Vaught, J.L.4
-
78
-
-
77950680730
-
Akt/PKB inhibits retrograde axonal degeneration in the nigro-striatal dopaminergic pathway in vivo
-
Presentation 741.7
-
Cheng HC, Oo TF, Kareva T, et al. Akt/PKB inhibits retrograde axonal degeneration in the nigro-striatal dopaminergic pathway in vivo. Abstr Soc Neurosci 2008, Presentation 741.7.
-
(2008)
Abstr Soc Neurosci
-
-
Cheng, H.C.1
Oo, T.F.2
Kareva, T.3
-
79
-
-
55849108858
-
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway
-
Park KK, Liu K, Hu Y, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008;322:963-966.
-
(2008)
Science
, vol.322
, pp. 963-966
-
-
Park, K.K.1
Liu, K.2
Hu, Y.3
-
80
-
-
77952909073
-
Restoration of the nigro-striatal dopaminergic pathway in mouse models of Parkinson's disease: Effects of a constitutively active form of AKT
-
Presentation 247.19
-
Chen X, Kareva T, Rzhetskaya M, et al. Restoration of the nigro-striatal dopaminergic pathway in mouse models of Parkinson's disease: effects of a constitutively active form of AKT. Abstr Soc Neurosci 2008, Presentation 247.19.
-
(2008)
Abstr Soc Neurosci
-
-
Chen, X.1
Kareva, T.2
Rzhetskaya, M.3
|